Catalog No.
RHD36903
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Alpaca
Isotype
VHH-8His-Cys-tag
Clonality
Monoclonal
Target
Immunoglobulin kappa constant, Ig kappa chain C region, Ig kappa chain C region AG, Ig kappa chain C region CUM, Ig kappa chain C region EU, Ig kappa chain C region OU, Ig kappa chain C region ROY, Ig kappa chain C region TI, IGKC
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Purified by Nickel column.
Accession
P01834
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA2110
Local controlled release of stabilized monoclonal antibodies., PMID:40250626
Rigid enlargement of sybodies with antibody fragments for cryo-EM analyses of small membrane proteins., PMID:40108246
Monoclonal antibodies - A repertoire of therapeutics., PMID:39978966
Radiolabeled HER2-targeted molecular probes in breast cancer imaging: current knowledge and future prospective., PMID:39751821
Polybodies: Next-generation clinical antibodies., PMID:39369985
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders., PMID:38928395
Single domain antibodies from camelids in the treatment of microbial infections., PMID:38827746
Escherichia coli and Pichia pastoris: microbial cell-factory platform for -full-length IgG production., PMID:38797692
Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins., PMID:38691205
The role of venom proteomics and single-domain antibodies for antivenoms: Progress in snake envenoming treatment., PMID:38555033
Development of a platform method for rapid detection and characterization of domain-specific post-translational modifications in bispecific antibodies., PMID:38547650
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species., PMID:38352869
Expanding the Anti-Phl p 7 Antibody Toolkit: An Anti-Idiotype Nanobody Inhibitor., PMID:37987253
Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis., PMID:37971653
A fine-tuned yeast surface-display/secretion platform enables the rapid discovery of neutralizing antibodies against Clostridioides difficile toxins., PMID:37749574
NANOBODY® Molecule, a Giga Medical Tool in Nanodimensions., PMID:37686035
Recombinant Antibody Fragments for Neurological Disorders: An Update., PMID:37646225
The pComb3 Phagemid Family of Phage Display Vectors., PMID:37460147
Production of recombinant scorpion antivenoms in E. coli: current state and perspectives., PMID:37199752
Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments., PMID:37169114
Production of bioactive recombinant monoclonal antibody fragment in periplasm of Escherichia coli expression system., PMID:37040146
New insights into GPCR coupling and dimerisation from cryo-EM structures., PMID:36963163
VH-Based Mini Q-Body: A Novel Quench-Based Immunosensor., PMID:36850849
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type., PMID:36807826
Preparation and Characterization of Trastuzumab Fab-Conjugated Liposomes (Immunoliposomes)., PMID:36781762
NKp46-specific single domain antibodies enable facile engineering of various potent NK cell engager formats., PMID:36775946
A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy., PMID:36451856
Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells., PMID:36291540
Putting on molecular weight: Enabling cryo-EM structure determination of sub-100-kDa proteins., PMID:36248264
VHHs as tools for therapeutic protein delivery to the central nervous system., PMID:36192747
Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses., PMID:36158162
Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release., PMID:36104113
Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation., PMID:36018829
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL., PMID:35981465
Antibody variable region engineering for improving cancer immunotherapy., PMID:35822503
Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment., PMID:35716719
Encoding latent SuFEx reactive meta-fluorosulfate tyrosine to expand covalent bonding of proteins., PMID:35621237
Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications., PMID:35157266
Nanobody-based microfluidic human Fc assay for preclinical plasma quantification of IgG1/1.1 and IgG1-Fc-conjugates., PMID:34998814
Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins., PMID:34782475
Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies)., PMID:34620716
Recombinant antibodies and their use for food immunoanalysis., PMID:34417836
Antibody Fragment and Targeted Colorectal Cancer Therapy: A Global Systematic Review., PMID:34375187
Construction of Fluorescent Immunosensor Quenchbody to Detect His-Tagged Recombinant Proteins Produced in Bioprocess., PMID:34372230
Expression of antibody fragments in Saccharomyces cerevisiae strains evolved for enhanced protein secretion., PMID:34261490
Perspectives on metals-based radioimmunotherapy (RIT): moving forward., PMID:33995659
Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer's Disease., PMID:33967797
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response., PMID:33457075
Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers., PMID:33255488
Noncompetitive Fluorescence Polarization Immunoassay for Protein Determination., PMID:33094615
For research use only. Not for human or drug use.
